Search results
Results from the WOW.Com Content Network
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off .
IBA GROUP is an international IT company founded in 1993. [ 1 ] [ 2 ] The company’s focus areas include enterprise applications, mainframe systems, SAP solutions, cloud technologies, and RPA/ML/AI solutions.
(Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...
The negative comments aimed at McDonald's were the latest in what is known as "review bombing," where an establishment is hit with a litany of bad reviews based on a political view or an ...
In the summer of 2004 the Guardian newspaper saw a confidential report suggesting questionable accounting practices in iSOFT tracing back to 2002. [7] iSOFT sought [8] and obtained an injunction against the paper preventing publication of the story, and a Parliamentary Written Question was answered by the government saying that they had no plans to look into the matter.
Luigi Mangione, accused in the killing of UnitedHealthcare CEO Brian Thompson, will plead not guilty, according to his lawyer, Thomas Dickey.
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .